Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PEG-IFN-SA tolerability and pharmacokinetics in healthy volunteers
ChiCTR-TNRC-11001393Phase 4Completed
- Sponsor
- West China Hospital of Sichuan University
- Start
- Oct 2010
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label trial of peginterferon alfa-2a in chronic hepatitis (8 cohorts), sponsored by West China Hospital of Sichuan University. Primary endpoint: tolerability. Started Oct 2010; status: completed.
02
Drugs
peginterferon alfa-2a
03
Conditions
chronic hepatitis
Beyond the preview
Go deeper on ChiCTR-TNRC-11001393.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TNRC-11001393.